[04/12/19]
Posted on April 12, 2019 in Federal Advocacy
Published by: Hall Render
Congressional Leaders Discuss Health Care Priorities Congress’ top leaders, Senate Majority Leader Mitch McConnell (R-KY) and House Speaker Nancy Pelosi (D-CA), announced they are not embracing “Medicare for All” as a priority at the American Hospital Association’s annual Washington conference. Both leaders reinforced that each chamber will pursue largely separate health care agendas in... READ MORE
Tags: Affordable Care Act, medicaid, Medicare, PBM, pharmacy benefit managers
[02/15/19]
Posted on February 15, 2019 in Health Law News
Published by: Hall Render
Beginning April 1, 2019, Medicare Part C and D plans, PACE organizations and 1876 cost contract plans (“Plans”) will be required to deny payment for services rendered or prescriptions ordered by any provider on the new Centers for Medicare & Medicaid Services (“CMS”) Preclusion List. The Preclusion List, which was first made available to... READ MORE
Tags: cms, Listed Providers, Medicare Part C, Medicare Part D, National Provider Plan and Enumeration System, NPPES, pecos, pharmacy, pharmacy benefit managers, Preclusion List
[02/01/19]
Posted on February 1, 2019 in Health Law News
Published by: Hall Render
On January 31, 2019, the Department of Health and Human Services Office of Inspector General (“OIG”) issued a proposed rule that, if finalized, would eliminate Anti-Kickback Statute (“AKS”) safe harbor protection for prescription drug rebates paid by manufacturers to pharmacy benefit managers (“PBMs”), Medicare Part D plans and Medicaid managed care organizations (“Proposed Rule”).... READ MORE
Tags: Anti-Kickback Statute, Discount Safe Harbor, Drug Pricing, Drug Rebates, oig, pharmacy benefit managers, Point-of-Sale Discount, Price Transparency
[09/19/18]
Posted on September 19, 2018 in Health Law News
Published by: Hall Render
On August 7, 2018, the Centers for Medicare & Medicaid Services (“CMS”) issued a Memorandum (“Memorandum”) announcing a policy change to allow Medicare Advantage (“MA”) plans to implement step therapy programs for physician-administered and other Part B drugs. Step therapy is a type of prior authorization for drugs in which a health plan requires... READ MORE
Tags: 340B, Centers for Medicare and Medicaid Services, cms, MA plans, MA-PD plans, Medicare Advantage, Medicare Part B, pharmacy benefit managers, Step Therapy